Latest News

Wave Life Sciences has reported past interim Phase 1 INLIGHT data showing that a single 240 mg dose of WVE-007 in adults with overweight or obesity produced statistically significant, six‑month reductions in visceral fat and waist circumference, with preserved lean mass and a generally favorable safety profile. An intriguing insight is that WVE-007 delivered greater six‑month improvement in visceral fat‑to‑muscle ratio than weekly semaglutide in a trial enrolling people with higher average...

OceanFirst Financial (OCFC) is drawing attention after a recent 1 day move of 1.1%, adding to a roughly 4.7% gain over the past week and modest gains over the past month. See our latest analysis for OceanFirst Financial. The recent 7 day share price return of 4.7% adds to a 90 day gain of 3.1%, while the 1 year total shareholder return of 26.7% contrasts with a slightly negative 5 year total shareholder return. This suggests momentum has strengthened more recently than over the longer...

Recent analyst updates on PepsiCo (PEP) spotlight rising cost inflation and demand risks linked to Middle East tensions, while upcoming earnings and the company’s health focused product pipeline are drawing fresh attention from investors. See our latest analysis for PepsiCo. PepsiCo’s share price has been firming up recently, with a 1.53% 1 day and 12.21% 90 day share price return, while its 1 year total shareholder return of 11.38% contrasts with a softer 3 year record. If recent moves in...

Bank of Communications Co., Ltd. has released its full-year 2025 results, reporting higher net interest income and net income, and has proposed at its upcoming June 26, 2026 AGM a final cash dividend of RMB 1.684 per 10 shares (inclusive of tax), totaling RMB 14.88 billion, payable in July and August 2026 to eligible A- and H-shareholders. An interesting feature of these announcements is that net income increased while both basic and diluted earnings per share from continuing operations fell...

Meren Energy (TSX:MER) is back in focus after announcing a refinancing of its reserves based lending facility, expanding total commitments, extending maturities, and trimming average interest margins on its core debt funding. See our latest analysis for Meren Energy. The refinancing news follows a period of strong share price momentum, with a 90 day share price return of 29.89% and a 1 year total shareholder return of 48.01%, building on a 5 year total shareholder return of 147.69%. If this...

What Diamondback Energy’s Recent Performance Tells Investors Without a clear news catalyst, Diamondback Energy (FANG) has still drawn attention as the share price closed at $193.88, with recent returns ranging from a 1 day gain to mixed weekly performance. Over the past month the stock shows a 7.39% return, extending to 31.90% over the past 3 months and 27.27% year to date, with a 61.44% total return over the past year. See our latest analysis for Diamondback Energy. The recent move to a...

Liberty Energy (LBRT) has completed a US$475 million zero coupon convertible note offering due 2032, expanding its previously announced deal and bringing Goldman Sachs and J.P. Morgan Securities in as co lead underwriters. See our latest analysis for Liberty Energy. The financing comes as Liberty Energy's share price sits at US$28.10, with a 90 day share price return of 49.15% and a 1 year total shareholder return of 160.29%, indicating that momentum has been strong recently. If this kind of...

In March 2026, Tenable Holdings announced Tenable Hexa AI, an agentic AI engine within the Tenable One Exposure Management Platform that automates security workflows and coordinates machine-speed responses to cyber risk across IT, cloud, identity, OT and AI environments. By using its Exposure Data Fabric to understand how vulnerabilities, identities, assets, configurations and AI systems interact, Tenable Hexa AI aims to prioritize what matters most and orchestrate repeatable, human‑guided...

Short interest surge puts H2O America (HTO) under closer investor scrutiny A 210% jump in short interest in March has pushed H2O America (HTO) into focus, as a growing group of traders is positioning for downside and signaling expectations of elevated share price swings. See our latest analysis for H2O America. At a share price of US$59.18, H2O America has a 1-day share price return of 1.27% and a 90-day share price return of 18.69%. The 1-year total shareholder return of 14.40% contrasts...

Why NNN REIT (NNN) is on income investors’ radar NNN REIT (NNN) continues to attract attention as a long-tenured dividend payer, with 36 consecutive years of annual dividend increases and a portfolio of 3,692 net lease properties across the United States. The stock recently closed at $42.77, with a market value of about $8.1 billion. Recent total returns range from a negative month performance to gains over the past 3 months, year to date, and across the past 1, 3, and 5 years. See our latest...

Why Azorim-Investment Development & Construction (TASE:AZRM) Is Back on Investors’ Radars Azorim-Investment Development & Construction (TASE:AZRM) has drawn attention after reporting full year 2025 earnings alongside an updated annual dividend, giving investors fresh numbers to assess both profitability and shareholder returns. See our latest analysis for Azorim-Investment Development & Construction. The latest results and dividend update come after a choppy few months for the share price,...

Dividend decision and why it matters now Novozymes (CPSE:NSIS B) has drawn fresh investor attention after its Annual General Meeting approved an ordinary dividend of DKK 4.25 per A and B share, a higher regular payout compared with previous years. This move to distribute more cash gives you an additional lens on the stock, alongside its recent share price performance and the company’s position across food, bioenergy, household care, agriculture and health focused biosolutions. See our latest...

Peoples Bancorp recently reported three consecutive quarters of improving earnings per share, supported by strong loan portfolio growth and tighter cost control, and previously announced it would release its first quarter 2026 results and hold an earnings call on April 21, 2026. This pattern of loan-driven earnings improvement is giving the bank greater financial flexibility and could influence how investors view its longer-term prospects and risk profile. Next, we’ll examine how this run of...

Recently, HUB24 reported that earnings per share grew 79% year-on-year, revenue increased 24%, and EBIT margins remained stable, all against a backdrop of meaningful insider ownership. This combination of rapid earnings growth, solid revenue expansion, and significant insider investment highlights a strong alignment between management and shareholders. Next, we’ll examine how HUB24’s sharp earnings per share growth reshapes its existing investment narrative and future expectations. AI is...

Atour Lifestyle Holdings (NasdaqGS:ATAT) has been in focus after its latest quarterly report topped earnings expectations, completed the “2,000 Premier Hotels” initiative, and introduced a new three year “Brand Led Excellence” plan. See our latest analysis for Atour Lifestyle Holdings. Atour’s latest earnings beat and new “Brand Led Excellence” plan have arrived after a mixed share price stretch, with a 4.47% 7 day share price return but a 9.08% 90 day decline. At the same time, the 1 year...

In March 2026, Expro Group Holdings’ board approved a plan to move its corporate domicile from the Netherlands to the Cayman Islands, while the company also agreed to provide advanced GeoFlow™ surface well testing and related services to support VERCANA GmbH and Vulcan Energy’s Lionheart geothermal and lithium project in Europe. The planned redomicile highlights management’s focus on governance flexibility and corporate simplification, while the Lionheart engagement underscores Expro’s role...

Saia (SAIA) moved higher in response to broader market relief after reports that President Trump was considering de-escalation of the military conflict in Iran, which eased worries about energy costs and industrial activity. See our latest analysis for Saia. At a latest share price of $354.28, Saia has a 7 day share price return of 5.97% and a 1 year total shareholder return of 9.90%, suggesting recent momentum has picked up after a more measured longer term outcome. If this kind of move has...

CMS coding update puts Inspire Medical Systems (INSP) in focus Recent confirmation that new CMS hypoglossal nerve stimulation C codes will share the same APC 5465 as CPT 64582, keeping hospital facility fees broadly unchanged, has put Inspire Medical Systems (INSP) back on investor watchlists. See our latest analysis for Inspire Medical Systems. The latest CMS coding clarity arrives as the share price trades at US$54.99, with a 1 day share price return of 2.52% and a 7 day share price return...

Analyst optimism and recent stock move Recent upward revisions to earnings estimates and revenue forecasts for Everpure (PSTG), together with a consensus Outperform rating, have coincided with the stock outperforming the broader market in recent trading sessions. See our latest analysis for Everpure. At a share price of US$62.48, Everpure has recently posted a 2.31% 1 day share price return and a 5.93% 7 day share price return. However, its 90 day share price return shows a decline of 10.31%,...

Recent talks between EVN (WBAG:EVN) and China Energy Engineering Group Global regarding renewable energy, storage, LNG power, and wider infrastructure have brought the group’s energy transition plans and capital needs back into focus for investors. See our latest analysis for EVN. Those talks come on the back of a Virtual Austrian Conference appearance and grid investments such as the new Skopje substation. The share price is at €29.3 and recent momentum is positive, including a 6.93% year to...

Legend Biotech recently reported record quarterly sales and profitability milestones for its CARVYKTI multiple myeloma therapy, alongside expanded global access and the past removal of FDA REMS restrictions that had limited how patients were monitored and allowed to drive. These updates highlight how CARVYKTI has become one of the most widely used CAR-T treatments, supported by long-term survival data, growing manufacturing capacity and broader international launches that together could...

Recent trading in Descartes Systems Group (TSX:DSG) has drawn attention after a weak past 3 months, with the stock showing a negative 14.4% return despite annual increases in both revenue and net income. See our latest analysis for Descartes Systems Group. At around CA$99.49, Descartes Systems Group’s recent 1 day and 7 day share price gains contrast with its 90 day share price return of a 14.4% decline and 1 year total shareholder return of a 27.1% decline. This pattern suggests momentum has...

DXP Enterprises (DXPE) is back on investors' radar after its share price moved higher, accompanied by a recent wave of upward earnings estimate revisions and consistently strong buy ratings from all covering analysts. See our latest analysis for DXP Enterprises. The recent uptick in earnings expectations appears to be feeding into strong momentum, with the share price at $143.34, a 90 day share price return of 36.85% and a 1 year total shareholder return of 95.15% highlighting sustained...

In early April 2026, Celldex Therapeutics completed a follow-on public equity offering of 10,345,000 common shares at US$29.00 each, raising about US$300.01 million to support barzolvolimab launch preparation, pipeline development and general corporate needs. This financing closely followed detailed Phase 2 data showing barzolvolimab’s potential to meaningfully improve quality of life in difficult-to-treat chronic urticaria, underscoring Celldex’s focus on translating clinical momentum into...